Literature DB >> 26915463

Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia.

Constantine S Tam1,2, Thomas Kimber3,4, John F Seymour1,2.   

Abstract

Entities:  

Keywords:  BTK inhibition; chemotherapy; leptomeningeal; lymphoma; targeted therapy

Mesh：

Substances：

Year:  2016        PMID： 26915463     DOI： 10.1111/bjh.14000

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Biology of CNS lymphoma and the potential of novel agents.

Authors:  James L Rubenstein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Alipi V Naydenov; Lynne P Taylor
Journal:  Oncologist       Date:  2019-03-06

Review 3.  Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Authors:  Andrew Aw; Jennifer R Brown
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

4.  Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Tomohiko Tanigawa; Masatoshi Sakurai; Jun Kato; Kota Mizuno; Shinya Fujita; Yuya Koda; Taku Kikuchi; Takayuki Shimizu; Shinichiro Okamoto; Keisuke Kataoka
Journal:  Ann Hematol       Date:  2021-07-08       Impact factor: 3.673

5.  Brain biopsy in the diagnosis of leptomeningeal involvement in stage I chronic lymphocytic leukemia.

Authors:  Eva Cervilla Muñoz; Pablo Demelo Rodríguez; Alejandra García García; Javier Menarguez Palanca; Jorge Del Toro Cervera
Journal:  Clin Case Rep       Date:  2017-10-06

6.  Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.

Authors:  Donato Mannina; Barbara Loteta
Journal:  Case Rep Hematol       Date:  2017-07-16

7.  Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.

Authors:  Anna Christoforidou; Georgios Kapsas; Zoe Bezirgiannidou; Spyros Papamichos; Ιoannis Kotsianidis
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.